DiaMedica Therapeutics Inc. (DMAC)
NASDAQ·Healthcare·Biotechnology
$6.25
-1.11%
Mkt Cap $341.08M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$8.33
Range $7.00 – $10.00
Implied Upside
+33.3%
Consensus $8.33 vs current $6.25
NASDAQ·Healthcare·Biotechnology
$6.25
-1.11%
Mkt Cap $341.08M
No recent rating data.
Price Target (3 analysts)
$8.33
Range $7.00 – $10.00
+33.3%
Consensus $8.33 vs current $6.25